FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.
Frontier Biotechnologies said on Tuesday it has struck a deal with GSK GSK, granting the British drugmaker worldwide rights to develop two small interfering RNA therapies targeting kidney diseases in an agreement that could be worth up to $1 billion.
Popular Categories
© All content and intellectual rights of this website belong to Fansalaran — Website design and SEO by Omid Esmaeili.
